Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation.
about
The H19 non-coding RNA is essential for human tumor growthProlylcarboxypeptidase promotes angiogenesis and vascular repairProlylcarboxypeptidase (PRCP) as a new target for obesity treatmentRole of prolylcarboxypeptidase in angiotensin II type 2 receptor-mediated bradykinin release in mouse coronary artery endothelial cellsInfluence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosisHereditary angioedema attacks resolve faster and are shorter after early icatibant treatment.The plasma kallikrein-kinin system counterbalances the renin-angiotensin systemHighly selective hydrolysis of kinins by recombinant prolylcarboxypeptidase.Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factorHigh molecular weight kininogen activates B2 receptor signaling pathway in human vascular endothelial cellsNovel mechanism of plasma prekallikrein (PK) activation by vascular smooth muscle cells: evidence of the presence of PK activator.The involvement of proteoglycans in the human plasma prekallikrein interaction with the cell surface.Prolylcarboxypeptidase independently activates plasma prekallikrein (fletcher factor).Loss of prolyl carboxypeptidase in two-kidney, one-clip goldblatt hypertensive miceBradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin.Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin systemAngiotensin II type 2 receptor-stimulated activation of plasma prekallikrein and bradykinin release: role of SHP-1.Plasma Prekallikrein Is Associated With Carotid Intima-Media Thickness in Type 1 Diabetes.Human plasma kallikrein-kinin system: physiological and biochemical parametersPain on injection with microemulsion propofolPhysiologic activities of the contact activation system.The functional importance of the N-terminal region of human prolylcarboxypeptidase.Hereditary angioedema therapy: kallikrein inhibition and bradykinin receptor antagonism.Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammationBiochemical characterization of a novel high-affinity and specific plasma kallikrein inhibitor.Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin release.Overexpression of prolylcarboxypeptidase enhances plasma prekallikrein activation on Chinese hamster ovary cells.Assembly, activation, and signaling by kinin-forming proteins on human vascular smooth muscle cells.The effect of sodium nitrite infusion on renal function, brachial and central blood pressure during enzyme inhibition by allopurinol, enalapril or acetazolamide in healthy subjects: a randomized, double-blinded, placebo-controlled, crossover study
P2860
Q21144433-75FFFAF1-8BBA-486B-9085-EDC343BFBD67Q28586010-F213831F-5BFA-4183-8570-273E2152057EQ34046650-C9C73043-1704-4CF3-B744-ECBD7C47AE80Q34075614-99CAACE4-FF3E-4C01-9B79-DC9E2C9A3FEEQ34291787-109259DA-D716-4178-A3C5-068DEA29DBEDQ34579883-7D91CE45-B580-4D40-8B66-A6EAE86C9DF9Q34603054-4DED26A5-8EA6-4313-B497-4B264C3F9BFAQ34640018-F45D26FD-30E7-4922-9F75-40B1460E5F42Q35004987-90E777A9-32CD-4AEE-9C12-9E2FBECB2998Q35107342-C421238C-260D-49E6-A436-59C61A78BAB6Q35112051-5E634CBF-2FA5-416B-BF7C-D05D35BE34D4Q35118601-56A7C94B-E1DB-4898-92BD-91C33013A91FQ35206857-CF5DFF16-868F-4482-B709-E4F47B23B56DQ35565620-75253FC7-0CF2-45ED-A516-6C850D62F645Q35849803-24F7E2D3-BB5C-4103-A87B-1F239C3B5A9EQ35928293-E3F4B30F-4437-40F9-B628-E9A21EC90FB8Q36042466-CE7E3319-9DD8-4F1F-B741-574632053229Q36562533-658215E2-2426-4D4E-B083-AD55E3A8EB34Q36998879-E9BB70DA-1677-4EF9-83AB-1EC339EC17F2Q37173952-0F8F9E72-1F52-4BC1-B1A9-DCAE6DCCCE94Q39048978-E67038B4-83E0-4E3D-AC52-13EBF0DCC3E1Q39957249-EB9A28CB-4CF4-437A-8D1C-0DC72898102CQ41130419-4F0A2D38-D56C-45C5-BE6E-3A8C590093D2Q41904867-64C9D2C8-2E05-4B98-91CF-932C3E81A39BQ41982669-9513FF28-31BB-481B-82A4-94D0FF0814A3Q42148250-E54F39EA-71BB-40B2-86C4-E5F19A07A517Q46661267-CB401649-D3BD-48FD-AEC0-69B295D4EDE1Q53670507-AEB52C2D-3F21-493D-B85C-47BEA3086F17Q58706834-701FF7FF-AF1A-4C0F-AF25-33F0E30618B1
P2860
Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Assembly and activation of HK- ...... n liberation and NO formation.
@en
Assembly and activation of HK- ...... n liberation and NO formation.
@nl
type
label
Assembly and activation of HK- ...... n liberation and NO formation.
@en
Assembly and activation of HK- ...... n liberation and NO formation.
@nl
prefLabel
Assembly and activation of HK- ...... n liberation and NO formation.
@en
Assembly and activation of HK- ...... n liberation and NO formation.
@nl
P2093
P2860
P1476
Assembly and activation of HK- ...... n liberation and NO formation.
@en
P2093
P2860
P304
P356
10.1152/AJPHEART.2001.280.4.H1821
P577
2001-04-01T00:00:00Z